Groundbreaking discovery about a new potential treatment and prevention for post-traumatic stress disorder (PTSD) has now been discovered which could be boon to millions in years to come.

TOP INSIGHT
We believe this protein complex usually increases after severe stress, but in most cases, levels soon go back to baseline levels, however, in those who develop PTSD.
Read More..
"The discovery of the Glucocorticoid Receptor-FKBP51 protein complex provides a new understanding of molecular mechanisms underlying PTSD," said Dr. Liu. "We believe this protein complex normally increases after severe stress, but in most cases, levels soon go back to baseline levels. However, in those who develop PTSD, the protein complex remains persistently elevated, and so this could be a blood-based biomarker for PTSD as well as being a target for pharmacological treatment.
In addition, the peptide we developed could be given after a traumatic event, and could possibly prevent the patient from developing PTSD. This is a completely new approach to PTSD and for psychiatric disorders in general."
PTSD occurs in some people after experiencing or witnessing traumatic events, such as sexual assault or military combat. Patients can suffer from debilitating flashbacks, nightmares and anxiety, which can severely impact the quality of life. There are currently no laboratory diagnostic tests for PTSD, and existing treatments have limited efficacy. According to a recent study published in the British Journal of Psychiatry, Canada has the highest prevalence of PTSD among 24 examined countries, and 9.2 percent of Canadians will develop PTSD in their lifetimes. "We are thrilled this CAMH-led discovery can potentially help millions of people put the trauma behind them," added Dr. Liu.
The study has been supported by CIHR and the CAMH Discovery Fund. CAMH has filed a patent for the peptide and diagnostic aspect of Dr. Liu's invention. Dr. Liu and her team will conduct further testing and refining of the peptide before conducting human clinical trials.
MEDINDIA




Email










